(NASDAQ: IDYA) Ideaya Biosciences's forecast annual revenue growth rate of 148.83% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 82.88%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.63%.
Ideaya Biosciences's revenue in 2025 is $7,000,000.On average, 4 Wall Street analysts forecast IDYA's revenue for 2025 to be $1,275,215,631, with the lowest IDYA revenue forecast at $876,436,860, and the highest IDYA revenue forecast at $2,471,551,945. On average, 5 Wall Street analysts forecast IDYA's revenue for 2026 to be $5,758,190,170, with the lowest IDYA revenue forecast at $534,626,485, and the highest IDYA revenue forecast at $15,291,193,896.
In 2027, IDYA is forecast to generate $9,264,814,047 in revenue, with the lowest revenue forecast at $2,059,626,621 and the highest revenue forecast at $18,800,447,084.